NCT/Study#
NA /
HDAC/OX40
Phase I/II clinical trial of combination of OX40 and HDAC inhibitor in patients with Stage IV NSCLC
DISEASE GROUP:
Phase 1 Clinical Trials
current phase:
Phase I/II
STUDY STATUS:
Active
Location:
Hackensack, NJ
For More information:
Call 201-518-3587
